Home Page Overall Ranking ROE Ranking P/E Ranking Dividend Yield Capitalization Our eBook Our Book Contact










Isin US7170811035
Ticker PFE
Company PFIZER
Currency $
Price
Aware Investor Index (AII) 5.1108
Recommendation BUY
P/E 21.95
ROE 16.29 %
Capitalization 255,102,380,000 $
Dividend Yield 3.04 %
P/S 4.85
AII Position 136
P/E Position 321
ROE Position 201
Capitalization Position 19
Dividend Yield Position 244
Sales 52,546,000,000 $
10-Year Average Earnings 11,619,600,000 $
Shares Outstanding 6,058,000,000
Equity 71,308,000,000 $
Dividend per Share 1.28 $
Industry Pharmaceutical
Country United States
PFIZER Investor Relations Web Site http://www.pfizer.com/investors/







Sales:

YEAR MONTH AMOUNT
2017 12 52,546,000,000.00 $
2016 12 52,824,000,000.00 $
2015 12 48,851,000,000.00 $
2014 12 49,605,000,000.00 $
2013 12 51,584,000,000.00 $

Earnings:

YEAR MONTH AMOUNT
2017 12 21,308,000,000.00 $
2016 12 7,215,000,000.00 $
2015 12 6,960,000,000.00 $
2014 12 9,135,000,000.00 $
2013 12 22,003,000,000.00 $
2012 12 14,570,000,000.00 $
2011 12 10,009,000,000.00 $
2010 12 8,257,000,000.00 $
2009 12 8,635,000,000.00 $
2008 12 8,104,000,000.00 $

Equity:

YEAR MONTH AMOUNT
2017 12 71,308,000,000.00 $
2016 12 59,544,000,000.00 $
2015 12 64,998,000,000.00 $
2014 12 71,622,000,000.00 $
2013 12 76,620,000,000.00 $
2012 12 81,678,000,000.00 $
2011 12 82,621,000,000.00 $
2010 12 88,265,000,000.00 $

Shares Outstanding:

YEAR MONTH AMOUNT
2017 12 6,058,000,000
2016 12 6,159,000,000
2015 12 6,257,000,000
2014 12 6,424,000,000
2013 12 6,895,000,000
2012 12 7,508,000,000
2011 12 7,870,000,000
2010 12 8,074,000,000
2009 12 7,045,000,000

 












Bloomberg News for PFIZER:



Google News for PFIZER:

Motley Fool - 1 day ago
Is Pfizer a Buy?
It's been a long time since Pfizer (NYSE:PFE) shareholders have seen any revenue growth. Product sales peaked in 2010, but the company ...
TheStreet.com - 6 days ago
Pfizer and the Urge to Merge
Investors may have noticed Thursday's 2.4% decline in the market price for Dow Jones Industrial Average component Pfizer (PFE - Get Report) ...
Fairfield Current
Here's How Pfizer Gained 20.5% in 2018
Shares of Pfizer (NYSE:PFE) gained 20.5% in 2018, according to data from S&P Global Market Intelligence, while its industry was getting ...
NMSU Nеws
Pfizer (PFE) Gains But Lags Market: What You Should Know
Wall Street will be looking for positivity from PFE as it approaches its next earnings report date. This is expected to be January 29, 2019.
News Parents (press release)
This Biotech Stock Plunged On Its Looming Rivalry With Pfizer
On the stock market today, Pfizer stock sank 1.2%, to 42.37. The slide was in line with broader pharmaceutical stocks, which lost about 2% on ...
Motley Fool - 3 days ago
Investors Buy Shares of Pfizer (PFE) on Weakness
Traders bought shares of Pfizer Inc. (NYSE:PFE) on weakness during trading on Wednesday. $269.29 million flowed into the stock on the ...
Zacks.com - 2 days ago
Amarin: Evaluating The Merits Of A Potential Pfizer Acquisition
10, 2019, the shares of Amarin Corporation (AMRN) rallied over 22% due to the news that Pfizer (PFE) is interested in buying out the company.
Investor's Business Daily - 3 days ago
Will Pfizer Join The Buying Spree With This Small Biotech Stock?
Amarin (AMRN) stock bounded to a month high Thursday on a report that Dow Jones component Pfizer (PFE) could be interested in acquiring it ...
StreetInsider.com
Pfizer to shutter two plants in India
Throwing in the towel after years of trying to improve operations at two Hospira manufacturing sites in India, Pfizer (PFE +0.2%) has decided to ...
MarketWatch
Investors Sell Pfizer (PFE) on Strength (PFE)
Traders sold shares of Pfizer Inc. (NYSE:PFE) on strength during trading on Thursday. $105.51 million flowed into the stock on the tick-up and ...


Back